Oral antiviral medication started at the first sign of tingling is the single most effective treatment for cold sores. A one-day course of valacyclovir can shorten an outbreak by roughly a day compared to doing nothing, while topical creams and natural options offer smaller but still meaningful benefits. The real answer, though, depends on what you have access to, how quickly you act, and whether you are trying to treat an active sore or prevent future ones.
Oral Antivirals Are the Strongest Option
If you could pick only one weapon against a cold sore, it would be a short course of an oral antiviral like valacyclovir or famciclovir. In two large placebo-controlled trials, a single day of high-dose valacyclovir (two grams twice in one day) reduced the median outbreak duration by about a day and also cut healing time and pain compared to placebo.1PubMed Central. High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies Famciclovir as a single-day regimen produced similar improvements in healing and symptom resolution, though no head-to-head trial has directly compared the two drugs.2PubMed Central. Single-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacology
The appeal of oral antivirals is that they circulate through the bloodstream and reach infected nerve tissue in a way that a cream applied to the lip surface cannot. That systemic reach is why oral formulations tend to outperform topical ones, and why doctors often recommend them for people who get frequent or severe cold sores. You do need a prescription, but many clinicians will write one in advance so you can keep the pills on hand and start them the moment you feel that familiar tingle.
Topical Antivirals and Over-the-Counter Creams
Not everyone has a prescription ready to go, and that is where topical options come in. The two main prescription topical antivirals for cold sores are acyclovir cream and penciclovir cream. In clinical trials, acyclovir cream shortened the average outbreak by about half a day compared to a vehicle control, with mean episode durations of roughly four to five days on the cream versus five days or more on placebo.3PubMed Central. Acyclovir Cream for Treatment of Herpes Simplex Labialis: Results of Two Randomized, Double-Blind, Vehicle-Controlled, Multicenter Clinical Trials Penciclovir cream showed faster healing and pain resolution in a large multicenter trial, with benefits seen whether people started treatment early or late in the outbreak.4JAMA. Penciclovir Cream for the Treatment of Herpes Simplex Labialis: A Randomized, Multicenter, Double-blind, Placebo-Controlled Trial
The only truly over-the-counter antiviral cream in the United States is docosanol 10% (sold as Abreva). It works differently from acyclovir or penciclovir: rather than targeting viral replication directly, it blocks the virus from fusing with your cell membranes. In a large randomized trial of over 700 patients, docosanol-treated participants healed about 18 hours faster than those on placebo, and their pain and other symptoms resolved sooner.5Journal of the American Academy of Dermatology. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial When applied very early, at the prodromal tingling or redness stage, it shortened healing time by roughly three days compared to late application or placebo.6Acta Dermato-Venereologica. n-Docosanol 10% cream in the treatment of recurrent herpes labialis: a randomised, double-blind, placebo-controlled study One review concluded that docosanol’s overall effectiveness is roughly on par with prescription topical antivirals.7PubMed. Topical n-docosanol for management of recurrent herpes labialis
So if you cannot get a prescription quickly, docosanol applied at the first tingle is a reasonable substitute, though oral antivirals still have the edge for most people.
Why Timing Matters More Than the Product
Across almost every clinical trial on cold sore treatments, one finding comes through louder than anything else: the earlier you start, the better the result. Acyclovir cream worked whether therapy began at the prodrome stage or later, but the benefit was clearest with early application.3PubMed Central. Acyclovir Cream for Treatment of Herpes Simplex Labialis: Results of Two Randomized, Double-Blind, Vehicle-Controlled, Multicenter Clinical Trials Penciclovir showed the same pattern.4JAMA. Penciclovir Cream for the Treatment of Herpes Simplex Labialis: A Randomized, Multicenter, Double-blind, Placebo-Controlled Trial And docosanol’s three-day advantage over placebo appeared only in people who started during the prodromal or erythema stage; those who waited until blisters had already formed saw little difference.6Acta Dermato-Venereologica. n-Docosanol 10% cream in the treatment of recurrent herpes labialis: a randomised, double-blind, placebo-controlled study
This makes intuitive sense. Cold sores go through stages: tingling, redness, blister, ulcer, crust, and finally healed skin. Antiviral drugs work by slowing viral replication. Once billions of viral copies have already burst out of cells and formed a visible blister, there is much less replication left to block. Catching the sore during that first tingle, when the virus is still ramping up, gives the medication the largest window to limit damage. People who get frequent outbreaks often learn to keep medication on hand specifically so they can act within minutes of the first symptom.
Adding a Steroid to the Mix
One of the more interesting developments in cold sore treatment has been the combination of an antiviral with a mild topical corticosteroid. The idea is straightforward: the antiviral fights the virus while the steroid dials down the inflammation that causes much of the redness, swelling, and pain. A cream combining 5% acyclovir with 1% hydrocortisone was shown in a clinical trial to reduce both ulcerative and non-ulcerative recurrences and shorten healing time compared to acyclovir cream alone or placebo.8PubMed. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis
In a UV-light-triggered model of cold sores, the same combination reduced the rate of classic lesion development by about 29% compared to placebo and cut healing time by roughly a day.9PubMed Central. Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis A systematic review and meta-analysis pooling data from multiple trials found that patients receiving a combined antiviral-plus-steroid cream had significantly lower recurrence of ulcerative lesions compared to both placebo and antiviral treatment alone.10PubMed Central. Effectiveness of topical corticosteroids in addition to antiviral therapy in the management of recurrent herpes labialis: a systematic review and meta-analysis A network meta-analysis ranked the combination of oral valacyclovir with topical clobetasol as the single best-performing regimen, with a mean reduction in healing time of about three and a half days compared to placebo.11PubMed. Comparative Efficacy of Antiviral Agents for Prevention and Management of Herpes Labialis: A Systematic Review and Network Meta-Analysis
The catch is that you should not slap a steroid on a cold sore without an antiviral alongside it. A corticosteroid alone can theoretically suppress the local immune response enough to let the virus replicate more freely. It is the combination that works, not the steroid by itself.
Lysine and Other Supplements
Lysine is the supplement you will hear about most often from friends, health-food stores, and online forums. The theory is that the amino acid lysine competes with arginine, another amino acid the herpes virus needs to replicate. Shift the balance toward lysine and away from arginine, the thinking goes, and you starve the virus.
The evidence is mixed but not entirely dismissive. A double-blind trial giving 1,000 mg of lysine three times daily for six months found that the treatment group had on average about two and a half fewer outbreaks, reduced symptom severity, and faster healing.12Dermatologica. Success of L-Lysine Therapy in Frequently Recurrent Herpes simplex Infection: Treatment and Prophylaxis An earlier study using lower doses (312 to 1,200 mg daily) also reported reduced recurrence and faster recovery.13Dermatologica. A Multicentered Study of Lysine Therapy in Herpes simplex Infection However, a review of the broader evidence concluded that lysine at doses under one gram per day, without a low-arginine diet, appears ineffective. Only at doses above three grams per day did patients report a subjective improvement in their experience of the disease.14PubMed Central. Lysine for Herpes Simplex Prophylaxis: A Review of the Evidence
The positive trials were small, and the overall quality of the research is not in the same league as the antiviral drug trials. Lysine is unlikely to replace a proper antiviral, but for people who prefer a supplement-based approach or want to add something on top of standard treatment, higher doses (at least one gram three times daily) seem to be the threshold where any benefit appears.
Propolis, Lemon Balm, and Other Natural Remedies
Beyond lysine, a few natural substances have accumulated enough clinical trial data to be worth mentioning. Propolis, the resinous material bees use to seal their hives, has performed surprisingly well. A systematic review of bee-product trials found propolis superior to acyclovir in four out of six trials, with faster encrustation and shorter total healing time.15PubMed. Bee products and the treatment of blister-like lesions around the mouth, skin and genitalia caused by herpes viruses-A systematic review A separate systematic review of herbal treatments also found that propolis formulations shortened time to encrustation and complete healing compared to acyclovir, while lemon balm preparations reduced pain and swelling, sometimes with a decrease in lesion size compared to placebo.16PubMed. Herbal Medicine for Treating Herpes Labialis: A Systematic Review
These results are genuinely interesting, but the same caveats apply: the trials are generally small, the formulations vary widely between studies, and there is no standardized propolis or lemon balm product with FDA-approved labeling for cold sores. If you are drawn to natural options, propolis ointment has the strongest evidence base among them. Lemon balm (Melissa officinalis) lip balm or cream is a reasonable second choice for symptom relief, even if the evidence for shortened healing is thinner.
Light Therapy Devices
A less well-known treatment option is light therapy, sometimes called phototherapy or low-level laser therapy. A small randomized study compared a diode laser to acyclovir cream and found that the laser group recovered in an average of about two days, compared to roughly three and a half days for acyclovir and over four days for a sham laser.17PubMed Central. Comparing the effect of diode laser against acyclovir cream for the treatment of herpes labialis A pilot study testing a 1072-nm narrow-waveband light device found it healed cold sores in about four days compared to roughly eight and a half days with topical acyclovir.18Clinical and Experimental Dermatology. A pilot study of treatment of herpes labialis with 1072 nm narrow waveband light A later double-blind trial of the same device showed healing in about six days versus nine for placebo.19Clinical and Experimental Dermatology. A randomised double‐blind study comparing the effect of 1072‐nm light against placebo for the treatment of herpes labialis
Those numbers look impressive, but the studies are small and the devices are not widely available or cheap. Light therapy for cold sores sits in an evidence gray zone: promising enough to watch, not robust enough to recommend as a first-line treatment over well-studied antivirals. If you already have access to a device through a dental or dermatology office, it could be a useful adjunct.
Hydrocolloid Patches
Hydrocolloid cold sore patches (the best-known brand is Compeed) take a completely different approach. Rather than fighting the virus pharmacologically, they treat the cold sore as a wound. The patch creates a moist healing environment, protects the sore from external irritants, and prevents you from picking at the scab. A randomized clinical trial comparing a hydrocolloid patch to 5% acyclovir cream found comparable healing outcomes, with the patch offering the additional benefits of wound protection, discretion, and less social embarrassment.20PubMed. Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis
Patches will not shorten the viral replication phase, but they can keep the healing process on track by preventing the crust from cracking and re-opening. Many people find them most useful in the later stages of an outbreak, once blisters have already formed and antiviral medication has done what it can. They also serve a cosmetic purpose: a thin, nearly invisible patch is less noticeable than a crusty sore or a glob of white cream.
Preventing Outbreaks in the First Place
For people who deal with cold sores four or more times a year, suppressive therapy is worth discussing with a doctor. In two pooled double-blind trials, daily valacyclovir (500 mg once a day for four months) kept 60% of participants outbreak-free over that period, compared to 38% on placebo. It also delayed the time to first recurrence from about nine and a half weeks to about 13 weeks.21PubMed. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies This is not a cure, but for someone who dreads the next outbreak, daily suppressive therapy can meaningfully reduce how often it happens.
Beyond medication, trigger management plays a role. Sun exposure is one of the most well-documented reactivation triggers, and consistent use of a lip balm with SPF protection can reduce UV-induced outbreaks.22Dove Press (International Medical Case Reports Journal). Anxiety and Sun Exposure as Triggers for Herpes Labialis: A Case Report and Review of Literature The herpes virus hides in nerve tissue between outbreaks, and various stressors, including UV light, heat, illness, and hormonal shifts, can nudge it back into active replication.23PubMed Central. Mechanisms of herpes simplex virus type 1 reactivation Psychological stress has also been linked to recurrence: a prospective diary study found that people with frequent cold sores scored higher on standard measures of stress and negative mood, and periods of higher perceived stress were followed by outbreaks.24Stress and Health. A prospective diary study of the role of psychological stress and negative mood in the recurrence of herpes simplex virus (HSV1)
None of this means you can stress-manage your way out of cold sores entirely. The virus reactivates spontaneously in some people regardless of identifiable triggers.25PubMed Central. Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia But wearing SPF lip balm year-round, managing sleep and stress where you can, and having medication ready for the first sign of trouble is a practical prevention strategy that addresses the triggers you can actually control.
When Standard Treatments Stop Working
Most people who use oral or topical antivirals will find them reliably effective, but antiviral resistance is a real phenomenon. An estimated 4% to 7% of herpes isolates from immunocompromised patients show resistance to acyclovir-class drugs, and resistance has been documented in up to about 6% of immunocompetent patients with recurrent herpes keratitis (eye infections).26PubMed Central. Overcoming Resistance: A Comprehensive Review and Treatment Approach for Acyclovir-Resistant Herpes Simplex Keratitis If you find that your medication no longer seems to shorten outbreaks the way it once did, mention this to your doctor. Alternatives exist, including foscarnet, which works through a different mechanism and remains effective against most acyclovir-resistant strains.
Resistance is more of a concern for people who are immunosuppressed, such as organ transplant recipients or those with HIV, but it is not impossible in otherwise healthy individuals. This is another reason not to use antivirals indiscriminately: save episodic treatment for actual outbreaks, or use suppressive dosing as prescribed, rather than taking random doses that could theoretically encourage resistant strains.
Telling Cold Sores Apart from Other Lip Sores
Before loading up on antivirals, it is worth making sure you are actually dealing with a cold sore. The two conditions people most often confuse are cold sores (herpes labialis) and canker sores (aphthous ulcers). Cold sores almost always appear on or near the lips and start with a tingling or burning sensation before blisters form. Canker sores appear inside the mouth, on the soft tissue of the cheeks or tongue, and are not caused by a virus. Antiviral treatment will do nothing for a canker sore.
Recurrent sores around the mouth could also be caused by other conditions, including fungal infections, which become more likely in people with diabetes or weakened immune systems. If your sores are unusually persistent, very painful, or look different from your usual cold sore, getting a proper diagnosis matters before you choose a treatment. A doctor can typically tell the difference by appearance alone, though viral cultures or blood tests can confirm unclear cases.
A Virus with Deep Roots
If it is any consolation, herpes simplex virus type 1 has been with humanity for a very long time. Molecular clock analyses estimate that HSV-1 has been codiverging with its primate hosts for roughly six million years, all the way back to the split between human and chimpanzee lineages.27PubMed Central. Evolutionary Origins of Human Herpes Simplex Viruses 1 and 2 More than two-thirds of the global population carries at least one type of herpes simplex virus. Ancient DNA work on HSV-1 genomes from archaeological specimens has suggested that the current diversity of HSV-1 strains circulating in Europe may trace back only about five thousand years, with major lineage replacements coinciding with Bronze Age migrations.28PubMed Central. Ancient herpes simplex 1 genomes reveal recent viral structure in Eurasia
This evolutionary intimacy is part of why no treatment can eradicate the virus. HSV-1 has spent millions of years perfecting its ability to hide in nerve cells and reactivate periodically. Current treatments suppress outbreaks and reduce symptoms, but they do not clear the latent virus from your nervous system. A true cure would require either eliminating the hidden viral DNA from nerve ganglia or finding a way to keep the virus permanently dormant, both of which remain active areas of research but are not yet close to clinical reality.